Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Ulla A HvidtfeldtNaja H Rod

Abstract

Increased exposure to endogenous estrogen and/or insulin may partly explain the relationship of obesity, physical inactivity, and alcohol consumption and postmenopausal breast cancer. However, these potential mediating effects have not been formally quantified in a survival analysis setting. We combined data from two case-cohort studies based in the Women's Health Initiative-Observational Study with serum estradiol levels, one of which also had insulin levels. A total of 1,601 women (601 cases) aged 50 to 79 years who were not using hormone therapy at enrollment were included. Mediating effects were estimated by applying a new method based on the additive hazard model. A five-unit increase in body mass index (BMI) was associated with 50.0 [95% confidence interval (CI), 23.2-76.6] extra cases per 100,000 women at-risk per year. Of these, 23.8% (95% CI, 2.9-68.4) could be attributed to estradiol and 65.8% (95% CI, 13.6-273.3) through insulin pathways. The mediating effect of estradiol was greater (48.8%; 95% CI, 18.8-161.1) for BMI when restricted to estrogen receptor positive (ER(+)) cases. Consuming 7+ drinks/wk compared with abstinence was associated with 164.9 (95% CI, 45.8-284.9) breast cancer cases per 100,000, but no signi...Continue Reading

References

Jan 1, 1988·Statistics in Medicine·J D Kalbfleisch, J F Lawless
Sep 6, 1995·Journal of the National Cancer Institute·S E HankinsonF E Speizer
Jan 1, 1993·Medicine and Science in Sports and Exercise·B E AinsworthR S Paffenbarger
Jan 14, 1998·Cancer Causes & Control : CCC·H V ThomasT J Key
Feb 28, 1998·JAMA : the Journal of the American Medical Association·S A Smith-WarnerD J Hunter
Sep 21, 2000·American Journal of Epidemiology·P A van den BrandtD J Hunter
May 3, 2001·Journal of the National Cancer Institute·J F DorganP R Taylor
Mar 27, 2002·International Journal of Epidemiology·Stephen R Cole, Miguel A Hernán
Apr 18, 2002·Journal of the National Cancer Institute·T KeyUNKNOWN Endogenous Hormones and Breast Cancer Collaborative Group
Aug 21, 2003·Journal of the National Cancer Institute·T J KeyUNKNOWN Endogenous Hormones Breast Cancer Collaborative Group
Sep 11, 2003·JAMA : the Journal of the American Medical Association·Anne McTiernanUNKNOWN Women's Health Initiative Cohort Study
Oct 25, 2003·Annals of Epidemiology·Garnet L AndersonRoss L Prentice
Oct 25, 2003·Annals of Epidemiology·Jennifer HaysJacques E Rossouw
Oct 25, 2003·Annals of Epidemiology·J David CurbUNKNOWN WHI Morbidity and Mortality Committee
Oct 28, 2004·Epidemiologic Perspectives & Innovations : EP+I·Jay S KaufmanSol Kaufman
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Steven R CummingsJane A Cauleys
Dec 31, 2005·International Journal of Cancer. Journal International Du Cancer·Sabina RinaldiRudolf Kaaks
Apr 21, 2006·American Journal of Epidemiology·Stephanie A Smith-WarnerDavid J Hunter
Nov 8, 2006·The Journal of Steroid Biochemistry and Molecular Biology·Anne KendallMitch Dowsett
Nov 30, 2006·Epidemiology·Evelyn M MonninkhofUNKNOWN TFPAC
Jul 25, 2007·Nature Reviews. Cancer·Helmut K Seitz, Felix Stickel
Dec 11, 2007·International Journal of Cancer. Journal International Du Cancer·Reiko SuzukiAlicja Wolk
Dec 25, 2008·Methods in Molecular Biology·Yvonne M Coyle
Jan 1, 2009·Journal of the National Cancer Institute·Marc J GunterHoward D Strickler
Jan 7, 2009·International Journal of Cancer. Journal International Du Cancer·Naja Hulvej RodMorten Grønbaek
Jan 7, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Heather K NeilsonRobert C Millikan
Mar 6, 2009·International Journal of Epidemiology·Danella M Hafeman, Sharon Schwartz
Jul 10, 2009·International Journal of Cancer. Journal International Du Cancer·Geoffrey C KabatThomas E Rohan
Aug 25, 2010·Journal of the National Cancer Institute·Christopher I LiRoss Prentice
Feb 19, 2011·Journal of the National Cancer Institute·Ghada N FarhatJennifer S Lee
May 10, 2011·Epidemiology·Theis Lange, Jørgen V Hansen
Jun 7, 2011·The New England Journal of Medicine·Paul E GossUNKNOWN NCIC CTG MAP.3 Study Investigators
Jul 21, 2011·British Journal of Cancer·UNKNOWN Endogenous Hormones and Breast Cancer Collaborative GroupH D Strickler
Jul 30, 2011·Alcoholism, Clinical and Experimental Research·Vatsalya VatsalyaVijay A Ramchandani

❮ Previous
Next ❯

Citations

Aug 1, 2012·Breast Cancer Research and Treatment·Nananda F ColRowan T Chlebowski
Oct 1, 2013·The Breast : Official Journal of the European Society of Mastology·Pamela J Goodwin
Apr 1, 2014·Epidemiology·Rebecca AnthopolosMarie Lynn Miranda
Nov 23, 2013·American Journal of Epidemiology·Theis LangeLau Caspar Thygesen
Jun 26, 2014·Surgery·Christopher T KellyWalter J Pories
Apr 18, 2014·Endocrine-related Cancer·Marjory Alana MarcelloLaura Sterian Ward
Jan 1, 2014·Translation·Argun AkcakanatFunda Meric-Bernstam
May 28, 2016·International Journal of Environmental Research and Public Health·Yue ZhouHua-Bin Li
Jul 18, 2015·Journal of the National Cancer Institute·Marc J GunterGloria Y F Ho
May 11, 2017·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·G A BrayUNKNOWN World Obesity Federation
Mar 9, 2018·Endocrine Reviews·George A BrayThomas H Inge
Apr 5, 2019·International Journal of Epidemiology·Josef FritzHanno Ulmer
Apr 11, 2019·International Journal of Cancer. Journal International Du Cancer·Nada AssiPietro Ferrari
Feb 6, 2020·Biometrical Journal. Biometrische Zeitschrift·Theis Lange, Aksel K G Jensen
May 15, 2013·The Journal of Clinical Endocrinology and Metabolism·Michael E JonesAnthony J Swerdlow
Jan 1, 2017·Expert Review of Endocrinology & Metabolism·Pamela J Goodwin
Jun 13, 2019·International Journal of Cancer. Journal International Du Cancer·S Ghazaleh DashtiDallas R English
Sep 11, 2020·Nature Reviews. Cancer·Emily J Gallagher, Derek LeRoith
Dec 7, 2018·JAMA Oncology·Isabel PimentelPamela J Goodwin
Dec 8, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Catherine SchairerRegina G Ziegler
Jan 17, 2015·Cancer Research·Marc J GunterHoward D Strickler
Feb 23, 2021·Current Addiction Reports·Francina FonsecaMarta Torrens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.